FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to peptide vaccines against cancer. There are presented epitope peptides derived from the TTK gene that elicit CTL development, pharmaceutical compositions containing as active ingredients the above peptides or polynucleotides coding the peptides.
EFFECT: there are presented antigen-presenting cells and recovered CTLs which target the above peptides and methods for inducing the antigen-presenting cells or CTLs.
18 cl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MPHOSPH1 PEPTIDES AND VACCINES CONTAINING THEM | 2012 |
|
RU2612905C2 |
| TOPK PEPTIDES AND THEIR VACCINES | 2012 |
|
RU2633503C2 |
| PEPTIDE CANCER VACCINES EXPRESSING TUMOUR-SPECIFIC ANTIGENS | 2008 |
|
RU2464275C2 |
| UBE2T PEPTIDE AND VACCINES CONTAINING THE SAME | 2013 |
|
RU2663350C2 |
| HJURP PEPTIDES AND VACCINES CONTAINING THEM | 2011 |
|
RU2570560C2 |
| KNTC2 PEPTIDES AND VACCINES CONTAINING THE SAME | 2014 |
|
RU2671395C2 |
| EPITOPE WDRPUH PEPTIDES AND VACCINES, CONTAINING THEM | 2009 |
|
RU2514386C2 |
| PEPTIDE VACCINES FOR CANCER EXPRESSING MPHOSPH1 OR DEPDC1 POLYPEPTIDES | 2007 |
|
RU2469044C2 |
| TEM8 PEPTIDES AND VACCINES CONTAINING THEM | 2008 |
|
RU2498993C2 |
| NEIL3 PEPTIDES AND VACCINES INCLUDING SAME | 2010 |
|
RU2600888C2 |
